Company intelligence / Profile preview

Ante.is

San Francisco, California, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Ante is a health technology company focused on longevity and healthspan optimization through advanced biological age testing. The company provides users with epigenetic testing kits that measure biological age and rate of aging, coupled with a digital platform that offers personalized health recommendations. By integrating biomarker data with lifestyle tracking, Ante aims to help individuals slow down the aging process and prevent chronic diseases. Their services are designed for proactive health management, moving beyond traditional reactive medicine to a data-driven, preventative approach.

Therapeutic areas: OtherMetabolic Disorders
Modalities: DiagnosticData-driven health optimization
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Ante.is.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ante.is.

Explore the full profile